16 insiders have filed at AUPH since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Tang Kevin | Director | 12.23M | 8.885% | 18 buys $49.8M | |
| Greenleaf Peter | Chief Executive Officer | 1.84M | 1.337% | 3 sells $3.6M | |
| Donley Matthew Maxwell | Chief Operating Officer | 680.3k | 0.494% | 3 sells $1.2M | |
| Miller Joseph M | Chief Financial Officer | 576.4k | 0.419% | 3 sells $1.1M | |
| Robertson Stephen P. | EVP, General Counsel | 505.9k | 0.368% | 3 sells $1.3M | |
| Habig Scott Michael | Chief Commercial Officer | 456.3k | 0.332% | 3 sells $283k | |
| Knappertz Volker | EVP, Research And Development | 319.1k | 0.232% | 2 sells $168k | |
| Keenan Greg | SVP, Chief Medical Officer | 154.4k | 0.112% | 3 sells $376k | |
| Jayne David R.W. | Director | 56.5k | 0.041% | 1 sells $28k | |
| Billen Daniel | Director | 28.1k | 0.02% | 1 sells $30k | |
| Leversage Jill | Director | 25.1k | 0.018% | 1 sells $32k | |
| Smith Karen L. | Director | 24.8k | 0.018% | 1 sells $44k | |
| Bailey Jeffrey Allen | Director | 22.8k | 0.017% | 1 sells $38k | |
| Mackay-Dunn R. Hector | Director | 18.6k | 0.014% | 1 sells $32k | |
| Balakrishnan Brinda | Director | 17.5k | 0.013% | 1 sells $3k | |
| Johnson Craig A | Director | 14.6k | 0.011% |
Full register at boothcheck.com/insiders/AUPH. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.